Johnson & Johnson agreed to pay $9.9 million to settle claims by the state of Kentucky that the company misrepresented the risks of vaginal-mesh products used to bolster sagging organs and treat incontinence in women.
The deal is part of J&J’s effort to wrap up more than a decade of litigation by thousands of women who claim the products — threaded into place through ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.